Search details
1.
Combined thioredoxin reductase and glutaminase inhibition exerts synergistic anti-tumor activity in MYC-high high-grade serous ovarian carcinoma.
Mol Ther
; 31(3): 729-743, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-36560881
2.
CX-5461 Enhances the Efficacy of APR-246 via Induction of DNA Damage and Replication Stress in Triple-Negative Breast Cancer.
Int J Mol Sci
; 22(11)2021 May 28.
Article
in English
| MEDLINE | ID: mdl-34071360
3.
Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer.
Int J Cancer
; 146(1): 123-136, 2020 01 01.
Article
in English
| MEDLINE | ID: mdl-31090219
4.
The Multifaceted Roles of DJ-1 as an Antioxidant.
Adv Exp Med Biol
; 1037: 67-87, 2017.
Article
in English
| MEDLINE | ID: mdl-29147904
5.
Targeted knockdown of DJ-1 induces multiple myeloma cell death via KLF6 upregulation.
Apoptosis
; 21(12): 1422-1437, 2016 12.
Article
in English
| MEDLINE | ID: mdl-27734217
6.
A design of experiments screen reveals that Clostridium novyi-NT spore germinant sensing is stereoflexible for valine and its analogs.
Commun Biol
; 6(1): 118, 2023 01 28.
Article
in English
| MEDLINE | ID: mdl-36709236
7.
Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia.
Leukemia
; 37(3): 636-649, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36670235
8.
Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-ß signaling pathways in cancer.
Cell Biosci
; 13(1): 132, 2023 Jul 21.
Article
in English
| MEDLINE | ID: mdl-37480151
9.
CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitors.
J Exp Clin Cancer Res
; 41(1): 355, 2022 Dec 21.
Article
in English
| MEDLINE | ID: mdl-36539830
10.
Correction: Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma.
Oncotarget
; 12(9): 948-949, 2021 Apr 27.
Article
in English
| MEDLINE | ID: mdl-33953848
11.
Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment.
Antioxidants (Basel)
; 9(3)2020 Mar 03.
Article
in English
| MEDLINE | ID: mdl-32138149
12.
Cep55 overexpression promotes genomic instability and tumorigenesis in mice.
Commun Biol
; 3(1): 593, 2020 10 21.
Article
in English
| MEDLINE | ID: mdl-33087841
13.
Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma.
Redox Biol
; 28: 101310, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31514052
14.
Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition.
Theranostics
; 10(12): 5259-5275, 2020.
Article
in English
| MEDLINE | ID: mdl-32373211
15.
RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC.
Theranostics
; 10(18): 7974-7992, 2020.
Article
in English
| MEDLINE | ID: mdl-32724453
16.
GSK3-ß Stimulates Claspin Degradation via ß-TrCP Ubiquitin Ligase and Alters Cancer Cell Survival.
Cancers (Basel)
; 11(8)2019 Jul 29.
Article
in English
| MEDLINE | ID: mdl-31362447
17.
Blockade of PDGFRß circumvents resistance to MEK-JAK inhibition via intratumoral CD8+ T-cells infiltration in triple-negative breast cancer.
J Exp Clin Cancer Res
; 38(1): 85, 2019 Feb 18.
Article
in English
| MEDLINE | ID: mdl-30777101
18.
CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer.
EMBO Mol Med
; 10(9)2018 09.
Article
in English
| MEDLINE | ID: mdl-30108112
19.
TrxR1 inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-Ðºß inhibition.
Cell Cycle
; 15(4): 559-72, 2016.
Article
in English
| MEDLINE | ID: mdl-26743692
20.
Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
Redox Biol
; 8: 175-85, 2016 08.
Article
in English
| MEDLINE | ID: mdl-26795735